As Pghs-2 and L-Pgds gene expression increase in the inflamed colonic mucosa of patients with active Crohn’s disease, the L-PGDS pathway may be a new therapeutic target in this disease (Le Loupp et al., 2015). The gene discussed is PTGS2; the disease is Crohn disease.